125 related articles for article (PubMed ID: 1721436)
1. Synergistic effect of FK 506 and donor-specific blood transfusion on rat skin but not on composite tissue (limb) allograft survival.
Kuroki H; Bean MA; Ikuta Y; Burgess EM
Transplant Proc; 1991 Dec; 23(6):3282-4. PubMed ID: 1721436
[No Abstract] [Full Text] [Related]
2. Effect of FK 506 and donor-specific blood transfusion on the rat composite tissue limb allograft and the mechanism of long-term graft survival.
Kuroki H; Bean MA; Ikuta Y; Akiyama M; Burgess EM
Transplant Proc; 1993 Feb; 25(1 Pt 1):658-61. PubMed ID: 7679833
[No Abstract] [Full Text] [Related]
3. FK 506 enhances the beneficial effects of donor-specific blood transfusion on allograft survival in rats.
Fabrega AJ; Blanchard JM; Braucher E; Dumble L; Rivas P; Pollak R
Transplant Proc; 1991 Dec; 23(6):3312-3. PubMed ID: 1721447
[No Abstract] [Full Text] [Related]
4. Effects of donor-specific transfusion, cyclosporine A and FK 506 on rat cardiac allograft survival.
Davies CB; Cofer BR; Alexander JW
Transplant Proc; 1991 Dec; 23(6):3314-5. PubMed ID: 1721448
[No Abstract] [Full Text] [Related]
5. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
[No Abstract] [Full Text] [Related]
6. Effect of FK 506 on graft survival in rat small intestinal allografts.
Date K; Okajima K; Takeda Y; Isozaki H; Tezuka K; Ryo T
Transplant Proc; 1992 Jun; 24(3):1173. PubMed ID: 1376516
[No Abstract] [Full Text] [Related]
7. Effect of FK 506 on the survival of rat small bowel allografts.
Takeda Y; Okajima K; Iga C; Date K; Ryo T; Niki M; Asaka K; Tezuka K; Isozaki H
Transplant Proc; 1991 Dec; 23(6):3251. PubMed ID: 1721426
[No Abstract] [Full Text] [Related]
8. Sentinel skin allograft-a reliable marker for monitoring of composite tissue transplant rejection.
Zamfirescu DG; Owen E; Lascar I; Molitor M; Zegrea I; Popescu M; Bishop GA; Lauer CA; Simionescu M; Climov M; Lanzetta M
Transplant Proc; 2009 Mar; 41(2):503-8. PubMed ID: 19328913
[TBL] [Abstract][Full Text] [Related]
9. Donor leukocytes combine with immunosuppressive drug therapy to prolong limb allograft survival.
Kanatani T; Lanzetta M; Owen E; Matsumoto T; Fujioka H; Kurosaka M; McCaughan GW; Bishop GA
Transplant Proc; 2005 Jun; 37(5):2382-4. PubMed ID: 15964421
[TBL] [Abstract][Full Text] [Related]
10. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
11. Prolonged limb allograft survival with short-term treatment with FK-506 in rats.
Arai K; Hotokebuchi T; Miyahara H; Arita C; Mohtai M; Sugioka Y; Kaibara N
Transplant Proc; 1989 Feb; 21(1 Pt 3):3191-3. PubMed ID: 2468256
[TBL] [Abstract][Full Text] [Related]
12. Effect of donor-specific transfusion and FK 506 on small intestine allotransplantation.
Fukuzawa M; Santiago S; Nakata S; Shirakura R; Okada A
Transplant Proc; 1991 Dec; 23(6):3252-4. PubMed ID: 1721427
[No Abstract] [Full Text] [Related]
13. Nerve regeneration of vascularized rat limb allograft and functional recovery of long-term graft survivals treated by short course of FK 506 or cyclosporine.
Kuroki H; Ikuta Y
Transplant Proc; 1995 Feb; 27(1):348-50. PubMed ID: 7533405
[No Abstract] [Full Text] [Related]
14. Role of thymus in operational tolerance induction in limb allograft transplant model.
Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
[TBL] [Abstract][Full Text] [Related]
15. Induction of tolerance by intrathymic injection of donor bone marrow cells in the rat: simultaneous heart and skin allograft model.
Imanishi M; Matsuura T; Hara Y; Tahara H; Kurita T
Transplant Proc; 1994 Aug; 26(4):1958-9. PubMed ID: 7520615
[No Abstract] [Full Text] [Related]
16. Intraportal donor-specific transfusion given 24 hours before small bowel transplantation with cyclosporine and FK 506.
Takara T; Tchervenkov JI; Guttman FM; Fecteau A; Rosenmann E
Transplant Proc; 1994 Jun; 26(3):1622. PubMed ID: 7518150
[No Abstract] [Full Text] [Related]
17. Enhancement of allograft survival by single intraoperative donor-specific blood transfusion combined with FK506.
Fabrega AJ; Blanchard JM; Rivas PA; Pollak R
Transplantation; 1993 Dec; 56(6):1579-80. PubMed ID: 7506458
[No Abstract] [Full Text] [Related]
18. Induction of long-term rat renal allograft survival: a specific synergistic effect of limited pretransplant cyclosporine combined with multiple nonspecific blood transfusions.
Martin DC; Hewitt CW; Black KS; Reyes M; Go C
Transplant Proc; 1987 Feb; 19(1 Pt 1):462-3. PubMed ID: 3274807
[No Abstract] [Full Text] [Related]
19. Trafficking of donor-derived bone marrow correlates with chimerism and extension of composite allograft survival across MHC barrier.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Yoder B; Siemionow M
Transplant Proc; 2006 Jun; 38(5):1625-33. PubMed ID: 16797371
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive effects of FK 506 on rat renal allograft survival, in comparison with cyclosporine.
Jiang H; Fujitsu T; Sakuma S; Ogawa T; Tamura K; Fujii Y; Akiyama Y; Izumi S; Takahara S; Ishibashi M
Transplant Proc; 1995 Feb; 27(1):367-9. PubMed ID: 7533413
[No Abstract] [Full Text] [Related]
[Next] [New Search]
